Nuvilex Inc., of Silver Spring, Md., said partner Austrianova Singapore Pty Ltd., of Singapore, signed a contract to establish regional headquarters and an R&D facility at the Thailand Science Park near Bangkok. The facilities will be used for the encapsulation, using the Cell-in-the-Box technology, of live cancer prodrug-activating cells that are part of Nuvilex’s pancreatic cancer treatment and that will be used in the company’s late-phase trials.